Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cicatricell is a topical anti-scarring cream developed for the management and reduction of scars resulting from surgical incisions, wounds, or burns. It is designed to be applied to healing tissue after the removal of sutures or staples, with the goal of improving the aesthetic appearance, texture, and color of the scar. The formulation is intended to minimize the formation of hypertrophic scars and keloids by optimizing the skin's remodeling process during the post-operative recovery phase. Clinical evaluation of the product involves long-term application (typically 2 to 6 months) to assess its efficacy in reducing scar prominence compared to untreated surgical sites.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cicatricell.